The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility and reimbursement for expanded genomic panel testing in adult oncology.
 
Susan Jean Hsiao
Consulting or Advisory Role - Bristol-Myers Squibb; Loxo; Ventana Medical Systems
Research Funding - Bristol-Myers Squibb
 
Anthony Sireci
Employment - Loxo
Stock and Other Ownership Interests - Loxo
Research Funding - UnitedHealthcare (Inst)
 
Danielle Pendrick
No Relationships to Disclose
 
Christopher Freeman
No Relationships to Disclose
 
Jessica Yang
No Relationships to Disclose
 
Gary K. Schwartz
Stock and Other Ownership Interests - Abbott; Abbvie; Becton Dickinson; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Merck; Pfizer
Honoraria - Array BioPharma; Bayer; Daiichi Sankyo; DarwinHealth; Ellipses Pharma; Fortress Biotech; Human Longevity, Inc; Iovance Biotherapeutics; Pfizer; PTC Therapeutics; PureTech
Consulting or Advisory Role - Array BioPharma; Bayer; Bionaut Labs; Daiichi Sankyo; DarwinHealth; Ellipses Pharma; Fortress Biotech; Gencirq; Human Longevity, Inc; Iovance Biotherapeutics; Pfizer; PTC Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals; Calithera Biosciences (Inst); Daiichi Sankyo (Inst); Fortress Biotech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
Travel, Accommodations, Expenses - Array BioPharma; Daiichi Sankyo; Iovance Biotherapeutics; PTC Therapeutics; PureTech
 
Mahesh M. Mansukhani
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Richard D. Carvajal
Consulting or Advisory Role - Aura Biosciences; Bristol-Myers Squibb; Castle Biosciences; Chimeron Bio; Compugen; Foundation Medicine; Genentech/Roche; Genzyme; I-Mab; Iconic Therapeutics; Immunocore; Incyte; Janssen Oncology; Merck; PureTech; Rgenix; Sorrento Therapeutics
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Immunocore (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst); Roche/Genentech (Inst)
 
Jennifer A. Oberg
No Relationships to Disclose